Three transactions announced in rapid succession — KKR’s acquisition of EDF Power Solutions in North America, ON Semiconductor’s $7 billion all-stock deal for Synaptics, and Merck KGaA’s $11.3 billion purchase of Bio-Techne — are not isolated events. Together, they form a coherent signal: cross-border mergers and acquisitions are accelerating along three structural axes — energy infrastructure, AI-enabled hardware, and life-sciences tooling. For CFOs, General Counsel, and M&A Directors operating in the mid-market, the implications are immediate and require deliberate strategic positioning.

Scale, Portfolio Reshaping, and the Return of Strategic Logic

The dominant narrative in corporate finance through much of 2023 and 2024 was dealmaker caution: rising interest rates, compressed multiples, and regulatory headwinds suppressed transaction volumes. What the current deal cluster reveals is a decisive shift. Buyers are no longer waiting for perfect conditions — they are acting on structural conviction.

EDF’s divestiture of its U.S. and Canadian power-solutions unit to KKR reflects a broader European utility trend: portfolio pruning to fund domestic energy transition commitments, while private equity absorbs cross-border infrastructure assets with long-duration cash flows. KKR’s appetite here is consistent with its broader infrastructure thesis, which has deployed tens of billions across regulated and contracted assets globally.

ON Semiconductor’s all-stock acquisition of Synaptics — valued at approximately $7 billion — is arguably the most strategically instructive deal of the cluster. It is a direct bet on physical AI: the convergence of edge computing, sensor fusion, and machine-learning inference in industrial and automotive devices. All-stock structures at this scale signal confidence in combined-entity valuation and reduce near-term leverage risk, a structure worth noting in an environment where debt financing remains selectively expensive.

Merck KGaA’s $11.3 billion move on Bio-Techne continues a well-documented consolidation wave in life-sciences tools and research reagents. The deal reinforces that buyers in regulated, IP-intensive sectors are willing to pay premium multiples for proprietary manufacturing capabilities and deep customer relationships — assets that are difficult to replicate organically.

Private Equity as Structural Counterparty — Not Just Opportunistic Buyer

Private equity’s role in the current M&A environment deserves precise framing. KKR’s involvement in the EDF transaction is emblematic of a broader pattern: sponsor capital is functioning as a structural counterparty to corporate portfolio strategy, not merely as an opportunistic acquirer of distressed or undervalued assets.

Mid-market companies should register this distinction carefully. When a sponsor of KKR’s scale acquires an infrastructure platform with cross-border regulatory exposure — spanning U.S. and Canadian energy markets — the due diligence and post-merger integration frameworks they deploy set a new benchmark. Sellers and targets in adjacent sectors should expect:

  • Deeper technology and cybersecurity due diligence, particularly where assets interface with critical national infrastructure
  • National-security review exposure under CFIUS (U.S.) and equivalent screening mechanisms in EU member states under the Foreign Subsidies Regulation and national FDI regimes
  • More granular representations and warranties around operational resilience, ESG compliance, and data governance

Simultaneously, mid-market transactions — including Mitie’s £3.1 billion takeover by OCS Group International and Utz Brands’ agreed sale to Intersnack — confirm that strategic portfolio logic is operating across size tiers, not only at the mega-cap level.

Implications for Decision-Makers: Valuation Pressure and Exit Readiness

For boards and executive teams evaluating M&A optionality in 2025, three actionable conclusions emerge from this deal environment:

  • Valuation benchmarks are being reset upward in AI-adjacent and life-sciences sectors. Companies with defensible technology positions or proprietary research tools should reassess their strategic value — both as potential targets and as acquirers of bolt-on capabilities.
  • Cross-border deal complexity is increasing, not decreasing. Regulatory scrutiny across the EU, UK, and U.S. — spanning antitrust, FDI screening, and sector-specific approvals — demands that General Counsel and compliance teams are integrated into deal planning from the earliest stages, not brought in at signing.
  • Exit readiness is a continuous discipline. The speed at which sponsors are deploying capital into infrastructure and industrials suggests that well-prepared sellers — with clean data rooms, audited technology stacks, and documented integration roadmaps — will command meaningfully better terms.

Key Takeaway

The current wave of large-scale cross-border M&A is not a temporary spike — it reflects durable structural forces: AI-driven consolidation, energy transition capital flows, and life-sciences platform building. Mid-market companies that treat M&A readiness as a strategic capability, rather than a reactive exercise, will be better positioned to capture value on both sides of the transaction table. The deals being signed today are defining the competitive landscape of 2027 and beyond.